{
  "meta": {
    "title": "23_Platelet_Disorders",
    "url": "https://brainandscalpel.vercel.app/23-platelet-disorders-b8d871a5.html",
    "scrapedAt": "2025-11-30T12:33:30.685Z"
  },
  "questions": [
    {
      "text": "Which of the following is the most potent vasoconstrictor?",
      "choices": [
        {
          "id": 1,
          "text": "Endothelin"
        },
        {
          "id": 2,
          "text": "Urotensin"
        },
        {
          "id": 3,
          "text": "Angiotensin"
        },
        {
          "id": 4,
          "text": "Vasopressin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most potent vasoconstrictor is <strong>urotensin2</strong>&nbsp;followed by endothelin and angiotensin.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0511",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is a component of δ granules of platelets?",
      "choices": [
        {
          "id": 1,
          "text": "Platelet-derived growth factor"
        },
        {
          "id": 2,
          "text": "Epinephrine"
        },
        {
          "id": 3,
          "text": "Fibrinogen"
        },
        {
          "id": 4,
          "text": "Platelet factor 4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Epinephrine</strong> is a component of&nbsp;<strong>&delta; granules</strong> of platelets.</p>\n<p>The different components of platelet granules are:&nbsp;</p>\n<ul>\n<li>&nbsp;&alpha; granules&nbsp;\n<ul>\n<li>Fibrinogen</li>\n<li>Fibronectin</li>\n<li>PF4</li>\n<li>Factor V, VIII&nbsp;</li>\n<li>PDGF</li>\n<li>TGF</li>\n</ul>\n</li>\n<li>&nbsp;&delta; granules&nbsp;\n<ul>\n<li>ADP</li>\n<li>Calcium</li>\n<li>Serotonin</li>\n<li>Histamine</li>\n<li>Epinephrine&nbsp;</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0476",
      "difficulty": "medium"
    },
    {
      "text": "Rees and Ecker diluting fluid is used in ______",
      "choices": [
        {
          "id": 1,
          "text": "Wintrobe tube"
        },
        {
          "id": 2,
          "text": "WBC Pipette"
        },
        {
          "id": 3,
          "text": "RBC Pipette"
        },
        {
          "id": 4,
          "text": "Hemoglobin pipette"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Rees and Ecker's solution</strong> is used as a diluting fluid in the&nbsp;<strong>RBC pipette</strong> for performing <strong>platelet counts</strong>. Its composition is:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Components</strong></td>\n<td><strong>Value</strong></td>\n</tr>\n<tr>\n<td>Sodium citrate</td>\n<td>3.8 g</td>\n</tr>\n<tr>\n<td>Formaldehyde (40 %)</td>\n<td>0.2 ml</td>\n</tr>\n<tr>\n<td>Brilliant cresyl blue</td>\n<td>0.1 g</td>\n</tr>\n<tr>\n<td>Distilled water</td>\n<td>100 ml</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The <strong>steps</strong> involved in <strong>platelet</strong> <strong>count</strong> are:</p>\n<p>I - Filling the pipette</p>\n<ul>\n<li>Diluting fluid is drawn to mark 1 of the RBC pipette and expelled</li>\n<li>Blood is aspirated to 0.5 mark of the RBCs diluting pipette</li>\n<li>Diluting fluid is aspirated to 101 mark</li>\n<li>Blood and diluting fluid are mixed mechanically for 5 min</li>\n</ul>\n<p>II - Filling the counting chamber</p>\n<ul>\n<li>Allow the counting chamber to stand for 20-30 minutes to allow the platelets to settle.</li>\n<li>To prevent drying out of the preparation, it should be kept in a moist atmosphere, this is most easily arranged by placing the filled counting chamber in the bottom of a clean Petri dish, alongside which arrange a small piece of cotton wool which has been soaked in water and squeezed out. Petri dish lid is additionally put over the dish.</li>\n<li>After 20-30minutes, the counting chamber can be removed and carefully transferred to the microscope stage.</li>\n</ul>\n<p>III - Counting the number of platelets</p>\n<ul>\n<li>Focus on the surface of the hemocytometer chamber with a high power dry objective. Dim the light to make the thrombocytes visible, and count all of the thrombocytes in the entire center 1 mm&sup2; (erythrocyte counting area) of both sides of the hemocytometer. This gives the number of thrombocytes in 0.2 l of 1: 200 dilution of blood.</li>\n<li>The number of thrombocytes counted X 1000 = number of thrombocytes/l of undiluted blood.&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6714",
      "difficulty": "hard"
    },
    {
      "text": "A 12-year-old girl with dengue hemorrhagic fever is being monitored by measuring platelet count. Spontaneous bleeding is associated with platelet values below _______ /µL.",
      "choices": [
        {
          "id": 1,
          "text": "30,000"
        },
        {
          "id": 2,
          "text": "50,000"
        },
        {
          "id": 3,
          "text": "20,000"
        },
        {
          "id": 4,
          "text": "10,000"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Spontaneous bleeding</strong>&nbsp;(non-traumatic) is associated with platelet values below <strong>20,000 platelets/&micro;L.</strong></p>\n<p>It most often involves small vessels. The common sites for such&nbsp;hemorrhages&nbsp;are:</p>\n<ul>\n<li>Skin</li>\n<li>Mucosa of gastrointestinal and genitourinary tracts</li>\n<li>Intracranial bleeding - most feared site of bleeding</li>\n</ul>\n<p>The <strong>production</strong> of the platelets is regulated by the hormone <strong>thrombopoietin</strong> produced in the liver.&nbsp;The platelet synthesis is also specifically <strong>increased</strong> by <strong>interleukin 6</strong>. The average <strong>lifespan</strong> of the platelets is<strong> 7&ndash;10 days</strong>. The <strong>normal</strong> platelet count is <strong>1,50,000 - 4,00,000</strong> /&micro;L.</p><hr><h3>Related Pearl: Causes of Thrombocytopenia</h3><p><strong>I.&nbsp;Decreased Production of Platelets</strong></p>\n<ol>\n<li>Selective impairment of platelet production<br />\n<ul>\n<li>Drug-induced: alcohol, thiazides, cytotoxic drugs</li>\n<li>Infections: measles, human immunodeficiency virus (HIV)</li>\n</ul>\n</li>\n<li>Nutritional deficiencies - B<sub>12</sub>, folate deficiency</li>\n<li>Bone marrow failure - aplastic anemia</li>\n<li>Bone marrow replacement - leukemia, disseminated cancer, granulomatous disease</li>\n<li>Ineffective hematopoiesis - myelodysplastic syndromes&nbsp;</li>\n</ol>\n<p><strong>II. Decreased Platelet Survival</strong></p>\n<ol>\n<li>Immunologic destruction\n<ul>\n<li>Primary autoimmune - chronic immune thrombocytopenic purpura, acute immune thrombocytopenic purpura</li>\n<li>Secondary autoimmune - systemic lupus erythematosus, B-cell lymphoid neoplasms</li>\n<li>Alloimmune - posttransfusion and neonatal</li>\n<li>Drug-associated - quinidine, heparin, sulfa compounds</li>\n<li>Infections - HIV, infectious mononucleosis (transient, mild), dengue fever</li>\n</ul>\n</li>\n<li>Nonimmunologic destruction\n<ul>\n<li>Disseminated intravascular coagulation</li>\n<li>Thrombotic microangiopathies</li>\n<li>Giant hemangiomas</li>\n</ul>\n</li>\n</ol>\n<p><strong>III. Sequestration -&nbsp;</strong>The&nbsp;spleen&nbsp;normally sequesters&nbsp;30% to 35%&nbsp;of&nbsp;platelets. This can rise to 80% to 90% when the spleen is enlarged, producing moderate degrees of thrombocytopenia.</p>\n<p><strong>IV. Dilution - </strong>Transfusions</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5827",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is true regarding functional platelet disorders?",
      "choices": [
        {
          "id": 1,
          "text": "Normal platelet count and normal bleeding time"
        },
        {
          "id": 2,
          "text": "Normal platelet count and increased bleeding time"
        },
        {
          "id": 3,
          "text": "Decreased platelet count and increased bleeding time"
        },
        {
          "id": 4,
          "text": "Decreased platelet count and decreased bleeding time"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Functional platelet disorders have <strong>normal platelet count</strong> and <strong>increased bleeding time</strong>.&nbsp;</p>\n<p><strong>Classification</strong> of platelet functional disorders:</p>\n<ul>\n<li>Defect in platelet-vessel wall interaction (<strong>disorders of adhesion</strong>)\n<ul>\n<li>Von Willebrand disease - deficiency or defect in plasma vWF</li>\n<li>Bernard&ndash;Soulier syndrome - deficiency or defect in GP Ib IX</li>\n</ul>\n</li>\n<li>Defects in platelet-platelet interaction (<strong>disorders of aggregation</strong>)\n<ul>\n<li>Congenital afibrinogenemia - deficiency of plasma fibrinogen</li>\n<li>Glanzmann thrombasthenia - deficiency or defect in GPIIb-IIIa</li>\n</ul>\n</li>\n<li><strong>Disorders of platelet secretion</strong> and signal transduction\n<ul>\n<li>Storage pool deficiency - &alpha;-Granule deficiency and gamma-Granule deficiency</li>\n<li>Quebec platelet disorder</li>\n<li>Chediak&ndash;Higashi syndrome</li>\n<li>Gray platelet syndrome</li>\n<li>Wiskott&ndash;Aldrich syndrome</li>\n</ul>\n</li>\n<li><strong>Disorders of platelet coagulation-protein interaction</strong>\n<ul>\n<li>Scott syndrome - defect in factor Va-Xa interaction on platelets</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Platelet disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8a852ed6ad094d22b4add695e1529e87x1280x1740.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Bernard&ndash;Soulier syndrome</strong></p>\n</td>\n<td>\n<p><strong>Glanzmann&rsquo;s thrombasthenia</strong></p>\n</td>\n<td>\n<p><strong>von Willebrand Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Inheritance</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>Most common (type 1): Autosomal dominant</td>\n</tr>\n<tr>\n<td>&nbsp;Defect</td>\n<td>\n<p>Absence of Gp Ib-IX-V receptor</p>\n</td>\n<td>Absence of&nbsp;Gp IIb/IIIa receptor</td>\n<td>\n<p>Type 1: Partial quantitative deficiency of&nbsp;von Willebrand factor (VWF)</p>\n<p>Type 2: Qualitative defect of VWF</p>\n<p>Type 3: Complete quantitative deficiency of VWF&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Mechanism</td>\n<td>\n<p>Lack of Gp Ib-IX-V prevents platelet <strong>adhesion</strong> to VWF</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Platelets cannot <strong>aggregate</strong> as Gp IIb/IIIa normally binds&nbsp;fibrinogen and forms bridges between platelets&nbsp;</p>\n</td>\n<td>\n<p>There are 2 mechanisms:</p>\n<p>Platelet <strong>adhesion</strong> defect - due to absent vWF that normally binds to GPIB-IX and collagen in the subendothelium</p>\n<p>Factor VIII deficiency as&nbsp;vWF usually prevents its degradation</p>\n</td>\n</tr>\n<tr>\n<td>Platelet count&nbsp;</td>\n<td>Normal platelet count/ mild thrombocytopenia&nbsp;</td>\n<td>Normal</td>\n<td>Normal (except in type 2B- thrombocytopenia)</td>\n</tr>\n<tr>\n<td>Platelet morphology</td>\n<td>Large platelets/ megathrombocytes with dense granules</td>\n<td>Normal</td>\n<td>&nbsp;Normal/ large</td>\n</tr>\n<tr>\n<td>Bleeding time</td>\n<td>\n<p>Prolonged</p>\n</td>\n<td>Prolonged</td>\n<td>&nbsp;Prolonged</td>\n</tr>\n<tr>\n<td>Platelet aggregation tests (collagen, ADP, thrombin)</td>\n<td>Normal</td>\n<td>Abnormal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td>Ristocetin aggregation test</td>\n<td>\n<p>Abnormal (platelets does not aggregate)</p>\n<p>Does not normalize&nbsp;after addition of normal serum</p>\n</td>\n<td>\n<p>Normal</p>\n<p>(aggregation of platelets)</p>\n</td>\n<td>Abnormal, Normalizes after addition of normal serum</td>\n</tr>\n<tr>\n<td>VWF factor levels</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>PT/PTT</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;PT normal, aPTT prolonged</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5842",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is false about vonWillebrand factor?",
      "choices": [
        {
          "id": 1,
          "text": "It is synthesized by hepatocytes"
        },
        {
          "id": 2,
          "text": "Its deficiency can also cause factor VIII defect"
        },
        {
          "id": 3,
          "text": "Its deficiency may cause defective platelet adhesion"
        },
        {
          "id": 4,
          "text": "It serves as a carrier for factor VIII"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Von Willebrand factor (<strong>vWF</strong>) is not synthesized by hepatocytes. They are <strong>produced</strong> by <strong>endothelial</strong> <strong>cells</strong> of <strong>liver</strong> and <strong>megakaryocytes</strong>. It&nbsp;is also found in:</p>\n<ul>\n<li>Platelet granules - lesser compared to endothelial cells</li>\n<li>Endothelial cells within cytoplasmic vesicles called Weibel-Palade bodies</li>\n<li>Subendothelium - binds to collagen</li>\n</ul>\n<p>It mediates the <strong>adhesion</strong> of <strong>platelets</strong> to sites of vascular injury (subendothelium). It links the exposed collagen to platelets. It facilitates platelet to platelet interaction and also stabilizes the hemostatic plug against shear forces.&nbsp;</p>\n<p>It is a carrier protein for factor VIII&nbsp;and also protects it from proteolytic degradation and&nbsp;stabilizes it.&nbsp;The&nbsp;<strong>half-life</strong> of <strong>factor</strong>&nbsp;<strong>VIII</strong> is about 2.4 hours when free and <strong>12 hours</strong> when <strong>bound</strong> to <strong>vWF</strong> in the circulation.</p>\n<p>Since vWF <strong>stabilizes</strong> <strong>factor VIII</strong>, a deficiency of vWF gives rise to a secondary decrease&nbsp;in factor VIII levels.&nbsp;This may be reflected by a prolongation of the partial thromboplastin time (PTT) in von Willebrand disease types 1 and 3.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4b48397155f047a8a2cf821bee2aa392x1280x2261.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5853",
      "difficulty": "medium"
    },
    {
      "text": "A 24-year-old woman is found to have uncontrolled bleeding after a minor cut injury. Her lab investigations are given below. Which of the following statements are false about her condition?<div class='question-desc-html'><p>Platelet count - 4,60,000 /μL</p>\n<p>Bleeding time - increased</p>\n<p>PT - normal</p>\n<p>APTT - increased</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Type 1 is most common"
        },
        {
          "id": 2,
          "text": "Type 2 is a qualitative defect"
        },
        {
          "id": 3,
          "text": "Type 3 is inherited as autosomal dominant"
        },
        {
          "id": 4,
          "text": "Type 3 is the severe form"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of <strong>von Willebrand disease</strong> (vWD). <strong>Type 3</strong> vWD is inherited as an <strong>autosomal recessive</strong> disease. </p>\n<p>The characteristics of different subtypes of vWD are:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Subtype</strong></p>\n</td>\n<td>\n<p><strong>Description</strong></p>\n</td>\n<td>\n<p><strong>Inheritance</strong></p>\n</td>\n<td>\n<p><strong>Lab findings</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type 1</p>\n</td>\n<td>\n<p>Quantitative deficiency of vWF</p>\n</td>\n<td>\n<p>Autosomal dominant</p>\n</td>\n<td>\n<p>Reduced vWF antigen, activity and Factor VIII</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type 2</p>\n</td>\n<td>\n<p>Qualitative defect in vWF</p>\n</td>\n<td>\n<p>Autosomal dominant</p>\n</td>\n<td>\n<p>Reduced vWF activity to antigen ration&lt;0.6</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type 3</p>\n</td>\n<td>\n<p>Near-complete (quantitative) deficiency of Factor VIII</p>\n</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>\n<p>Marked reduction or absence in Factor VIII levels</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Type</strong> <strong>1</strong> is the <strong>most common</strong> subtype of vWD. In Type 2, <strong>vWF</strong> is expressed in <strong>normal</strong> <strong>amounts</strong>, but missense mutations are present that lead to <strong>defective</strong> <strong>multimer</strong> <strong>assembly</strong>. This type has several subtypes, of which type <strong>2A</strong> is the <strong>most common</strong>.</p>\n<p><strong>Laboratory findings</strong> in vWD:</p>\n<ul>\n<li>Prolonged bleeding time</li>\n<li>Normal platelet count</li>\n<li>Hess test - positive tourniquet test due to defective platelet adhesion </li>\n<li>Ristocetin-induced aggregation - defective and diagnostic of this disease</li>\n<li>Platelet aggregation with ADP, collagen, and thrombin - normal</li>\n<li>Increased aPTT</li>\n</ul>\n<p>Though the synthesis of factor VIII remains normal, the half-life of VIII in plasma decreases due to reduced vWF (carrier) levels. This leads to <strong>secondary VIIIC deficiency</strong> in plasma. So, the intrinsic pathway of coagulation is affected. Hence, <strong>aPTT</strong> is <strong>increased</strong> in these patients.</p>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5859",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following occurs due to a defect in δ granules of the platelets?",
      "choices": [
        {
          "id": 1,
          "text": "Quebec platelet syndrome"
        },
        {
          "id": 2,
          "text": "Grey platelet syndrome"
        },
        {
          "id": 3,
          "text": "Wiskott–Aldrich syndrome"
        },
        {
          "id": 4,
          "text": "Hermansky–Pudlak syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Hermansky&ndash;Pudlak&nbsp;syndrome</strong> occurs due to a&nbsp;<strong>defect</strong> in platelet&nbsp;<strong>&delta; granules</strong>.</p>\n<p>Platelet granules disorders include:&nbsp;</p>\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"14\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><strong>Gray platelet syndrome</strong>&nbsp;- involves <strong>&alpha;</strong> granules and characterized by&nbsp;thrombocytopenia with large platelets&nbsp;that&nbsp;appear&nbsp;pale on the peripheral smear (due to deficiency of the &alpha; granules)</li>\n<li><strong>Quebec platelet syndrome</strong> - defect in<strong>&nbsp;&alpha; </strong>granules&nbsp;</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"14\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\"><strong>Hermansky&ndash;Pudlak&nbsp;syndrome</strong>&nbsp;- defect in&nbsp;<strong>&delta; </strong>granules and characterized by&nbsp;hypopigmentation and bleeding manifestation</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"14\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\"><strong>Wiskott&ndash;Aldrich syndrome</strong> - mutations in the&nbsp;<strong><em>WASp </em>gene&nbsp;</strong>expressed in the X chromosome and characterized by microthrombocytopenia, eczema, recurrent infections</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0477",
      "difficulty": "hard"
    },
    {
      "text": "A patient with large platelets on peripheral smear is diagnosed to have Bernard-Soulier disease. Deficiency of which of the following causes this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Gp IIb/ IIIa"
        },
        {
          "id": 2,
          "text": "Gp Ib/ IX"
        },
        {
          "id": 3,
          "text": "von Willebrand factor"
        },
        {
          "id": 4,
          "text": "Factor VIII"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\"><strong>Bernard&ndash;Soulier</strong> disease is due to <strong>deficiency</strong> of <strong>Gp Ib/ IX.</strong></p>\n<p class=\"p1\">Bernard&ndash;Soulier syndrome is characterized by<strong> large platelets</strong>. Ristocetin aggregation is abnormal.</p>\n<table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Deficiency</strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Defect</strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Gp Ib/IX</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Adhesion of platelets</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Bernard&ndash;Soulier syndrome</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Gp IIb/IIIa</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Aggregation of platelets</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Glanzmann thrombasthenia</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">von Willebrand factor</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Adhesion&gt;Aggregation</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Von Willebrand disease</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"p2\">Factor VIII deficiency causes hemophilia.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0c1e01cfa3e2477998ffbbf290baa16bx1280x2261.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Platelet disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8a852ed6ad094d22b4add695e1529e87x1280x1740.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Bernard&ndash;Soulier syndrome</strong></p>\n</td>\n<td>\n<p><strong>Glanzmann&rsquo;s thrombasthenia</strong></p>\n</td>\n<td>\n<p><strong>von Willebrand Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Inheritance</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>Most common (type 1): Autosomal dominant</td>\n</tr>\n<tr>\n<td>&nbsp;Defect</td>\n<td>\n<p>Absence of Gp Ib-IX-V receptor</p>\n</td>\n<td>Absence of&nbsp;Gp IIb/IIIa receptor</td>\n<td>\n<p>Type 1: Partial quantitative deficiency of&nbsp;von Willebrand factor (VWF)</p>\n<p>Type 2: Qualitative defect of VWF</p>\n<p>Type 3: Complete quantitative deficiency of VWF&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Mechanism</td>\n<td>\n<p>Lack of Gp Ib-IX-V prevents platelet <strong>adhesion</strong> to VWF</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Platelets cannot <strong>aggregate</strong> as Gp IIb/IIIa normally binds&nbsp;fibrinogen and forms bridges between platelets&nbsp;</p>\n</td>\n<td>\n<p>There are 2 mechanisms:</p>\n<p>Platelet <strong>adhesion</strong> defect - due to absent vWF that normally binds to GPIB-IX and collagen in the subendothelium</p>\n<p>Factor VIII deficiency as&nbsp;vWF usually prevents its degradation</p>\n</td>\n</tr>\n<tr>\n<td>Platelet count&nbsp;</td>\n<td>Normal platelet count/ mild thrombocytopenia&nbsp;</td>\n<td>Normal</td>\n<td>Normal (except in type 2B- thrombocytopenia)</td>\n</tr>\n<tr>\n<td>Platelet morphology</td>\n<td>Large platelets/ megathrombocytes with dense granules</td>\n<td>Normal</td>\n<td>&nbsp;Normal/ large</td>\n</tr>\n<tr>\n<td>Bleeding time</td>\n<td>\n<p>Prolonged</p>\n</td>\n<td>Prolonged</td>\n<td>&nbsp;Prolonged</td>\n</tr>\n<tr>\n<td>Platelet aggregation tests (collagen, ADP, thrombin)</td>\n<td>Normal</td>\n<td>Abnormal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td>Ristocetin aggregation test</td>\n<td>\n<p>Abnormal (platelets does not aggregate)</p>\n<p>Does not normalize&nbsp;after addition of normal serum</p>\n</td>\n<td>\n<p>Normal</p>\n<p>(aggregation of platelets)</p>\n</td>\n<td>Abnormal, Normalizes after addition of normal serum</td>\n</tr>\n<tr>\n<td>VWF factor levels</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>PT/PTT</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;PT normal, aPTT prolonged</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2442",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is false about Bernard-Soulier syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "There is defective adhesion of platelets to sub-endothelial matrix"
        },
        {
          "id": 2,
          "text": "Deficiency of the platelet membrane glycoprotein complex Ib-IX is seen"
        },
        {
          "id": 3,
          "text": "Platelet aggregation by ristocetin is normal"
        },
        {
          "id": 4,
          "text": "It has an autosomal recessive inheritance"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In <strong>Bernard&ndash;Soulier</strong> syndrome, platelet aggregation by <strong>ristocetin</strong> is abnormal.</p>\n<p>The&nbsp;<strong>receptor</strong> for <strong>vWF </strong>i.e.<strong>&nbsp;Ib-IX</strong>&nbsp;is essential for normal <strong>platelet adhesion</strong> to the subendothelial extracellular matrix. In this condition, there is&nbsp;<strong>deficiency</strong>&nbsp;of&nbsp;<strong>Gp Ib/ IX.&nbsp;</strong>Clinical manifestations include epistaxis, ecchymoses, menorrhagia, gingival bleeding, and gastrointestinal bleeding.</p>\n<p><strong>Laboratory findings</strong> seen in Bernard-Soulier syndrome:</p>\n<ul>\n<li>Prolonged bleeding time</li>\n<li>Moderate thrombocytopenia</li>\n<li>Platelet aggregation by ristocetin is deficient (but ADP, arachidonic acid, epinephrine, collagen - normal).</li>\n<li>Clot retraction - normal</li>\n<li>Abnormally large platelets</li>\n</ul>\n<p>The image given below shows the abnormally large platelets on peripheral smear seen in Bernard-Soulier syndrome.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d6c79ad5771a4dbe877613fdacf564d3x519x391.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/99d5b89d5c39449dbe3d65dedfd2492ex1280x2261.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Platelet disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8a852ed6ad094d22b4add695e1529e87x1280x1740.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Bernard&ndash;Soulier syndrome</strong></p>\n</td>\n<td>\n<p><strong>Glanzmann&rsquo;s thrombasthenia</strong></p>\n</td>\n<td>\n<p><strong>von Willebrand Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Inheritance</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>Most common (type 1): Autosomal dominant</td>\n</tr>\n<tr>\n<td>&nbsp;Defect</td>\n<td>\n<p>Absence of Gp Ib-IX-V receptor</p>\n</td>\n<td>Absence of&nbsp;Gp IIb/IIIa receptor</td>\n<td>\n<p>Type 1: Partial quantitative deficiency of&nbsp;von Willebrand factor (VWF)</p>\n<p>Type 2: Qualitative defect of VWF</p>\n<p>Type 3: Complete quantitative deficiency of VWF&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Mechanism</td>\n<td>\n<p>Lack of Gp Ib-IX-V prevents platelet <strong>adhesion</strong> to VWF</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Platelets cannot <strong>aggregate</strong> as Gp IIb/IIIa normally binds&nbsp;fibrinogen and forms bridges between platelets&nbsp;</p>\n</td>\n<td>\n<p>There are 2 mechanisms:</p>\n<p>Platelet <strong>adhesion</strong> defect - due to absent vWF that normally binds to GPIB-IX and collagen in the subendothelium</p>\n<p>Factor VIII deficiency as&nbsp;vWF usually prevents its degradation</p>\n</td>\n</tr>\n<tr>\n<td>Platelet count&nbsp;</td>\n<td>Normal platelet count/ mild thrombocytopenia&nbsp;</td>\n<td>Normal</td>\n<td>Normal (except in type 2B- thrombocytopenia)</td>\n</tr>\n<tr>\n<td>Platelet morphology</td>\n<td>Large platelets/ megathrombocytes with dense granules</td>\n<td>Normal</td>\n<td>&nbsp;Normal/ large</td>\n</tr>\n<tr>\n<td>Bleeding time</td>\n<td>\n<p>Prolonged</p>\n</td>\n<td>Prolonged</td>\n<td>&nbsp;Prolonged</td>\n</tr>\n<tr>\n<td>Platelet aggregation tests (collagen, ADP, thrombin)</td>\n<td>Normal</td>\n<td>Abnormal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td>Ristocetin aggregation test</td>\n<td>\n<p>Abnormal (platelets does not aggregate)</p>\n<p>Does not normalize&nbsp;after addition of normal serum</p>\n</td>\n<td>\n<p>Normal</p>\n<p>(aggregation of platelets)</p>\n</td>\n<td>Abnormal, Normalizes after addition of normal serum</td>\n</tr>\n<tr>\n<td>VWF factor levels</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>PT/PTT</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;PT normal, aPTT prolonged</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5844",
      "difficulty": "easy"
    },
    {
      "text": "A 4-year-old girl with a history of easy bruising was referred for further evaluation. Her previous lab reports showed that platelet count and morphology were normal. Platelet aggregations tests are given below. What is the likely diagnosis?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Agonist used</strong></td>\n<td><strong>Aggregation</strong></td>\n</tr>\n<tr>\n<td>ADP</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Epinephrine</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Collagen</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Ristocetin</td>\n<td>Normal</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "Bernard-Soulier syndrome"
        },
        {
          "id": 2,
          "text": "Grey platelet syndrome"
        },
        {
          "id": 3,
          "text": "von Willebrand Disease"
        },
        {
          "id": 4,
          "text": "Glanzmann thrombasthenia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of <strong>Glanzmann thrombasthenia</strong>.</p>\n<p>It is an abnormality of platelet <strong>GPIIb-IIIa</strong> (<strong>fibrinogen receptor</strong>).&nbsp;Platelets are unable to adhere to each other and to the underlying tissue of the damaged blood vessels. It is inherited in an&nbsp;<strong>autosomal recessive</strong>&nbsp;manner. The symptoms include&nbsp;mucocutaneous bleeding in the neonatal period, menorrhagia, ecchymoses, epistaxis, and gingival hemorrhage.</p>\n<p><strong>Types </strong>of&nbsp;Glanzmann thrombasthenia<strong>&nbsp;</strong>include:</p>\n<ul>\n<li>Type 1: Absence of GPIIb-IIIa</li>\n<li>Type 2: Reduced surface expression of GPIIb-IIIa/ Essentialis athrombia - clot retraction is normal</li>\n<li>Type 3: Dysfunction of GPIIb-IIIa</li>\n</ul>\n<p><strong>Laboratory features&nbsp;</strong>of&nbsp;Glanzmann thrombasthenia:</p>\n<ul>\n<li>Normal platelet count and morphology</li>\n<li>Platelet aggregation occurs in response to ristocetin, but not to other agonists (such as ADP, thrombin, collagen or epinephrine)</li>\n<li>Clot retraction is absent</li>\n</ul><hr><h3>Related Pearl: Platelet disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8a852ed6ad094d22b4add695e1529e87x1280x1740.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Bernard&ndash;Soulier syndrome</strong></p>\n</td>\n<td>\n<p><strong>Glanzmann&rsquo;s thrombasthenia</strong></p>\n</td>\n<td>\n<p><strong>von Willebrand Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Inheritance</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>Most common (type 1): Autosomal dominant</td>\n</tr>\n<tr>\n<td>&nbsp;Defect</td>\n<td>\n<p>Absence of Gp Ib-IX-V receptor</p>\n</td>\n<td>Absence of&nbsp;Gp IIb/IIIa receptor</td>\n<td>\n<p>Type 1: Partial quantitative deficiency of&nbsp;von Willebrand factor (VWF)</p>\n<p>Type 2: Qualitative defect of VWF</p>\n<p>Type 3: Complete quantitative deficiency of VWF&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Mechanism</td>\n<td>\n<p>Lack of Gp Ib-IX-V prevents platelet <strong>adhesion</strong> to VWF</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Platelets cannot <strong>aggregate</strong> as Gp IIb/IIIa normally binds&nbsp;fibrinogen and forms bridges between platelets&nbsp;</p>\n</td>\n<td>\n<p>There are 2 mechanisms:</p>\n<p>Platelet <strong>adhesion</strong> defect - due to absent vWF that normally binds to GPIB-IX and collagen in the subendothelium</p>\n<p>Factor VIII deficiency as&nbsp;vWF usually prevents its degradation</p>\n</td>\n</tr>\n<tr>\n<td>Platelet count&nbsp;</td>\n<td>Normal platelet count/ mild thrombocytopenia&nbsp;</td>\n<td>Normal</td>\n<td>Normal (except in type 2B- thrombocytopenia)</td>\n</tr>\n<tr>\n<td>Platelet morphology</td>\n<td>Large platelets/ megathrombocytes with dense granules</td>\n<td>Normal</td>\n<td>&nbsp;Normal/ large</td>\n</tr>\n<tr>\n<td>Bleeding time</td>\n<td>\n<p>Prolonged</p>\n</td>\n<td>Prolonged</td>\n<td>&nbsp;Prolonged</td>\n</tr>\n<tr>\n<td>Platelet aggregation tests (collagen, ADP, thrombin)</td>\n<td>Normal</td>\n<td>Abnormal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td>Ristocetin aggregation test</td>\n<td>\n<p>Abnormal (platelets does not aggregate)</p>\n<p>Does not normalize&nbsp;after addition of normal serum</p>\n</td>\n<td>\n<p>Normal</p>\n<p>(aggregation of platelets)</p>\n</td>\n<td>Abnormal, Normalizes after addition of normal serum</td>\n</tr>\n<tr>\n<td>VWF factor levels</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>PT/PTT</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;PT normal, aPTT prolonged</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5846",
      "difficulty": "medium"
    },
    {
      "text": "A 1-year-old boy is brought with a history of recurrent impetigo. Physical examination findings are given below. Platelet counts are low and peripheral smear shows abnormally small-sized platelets. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Idiopathic thrombocytopenia purpura"
        },
        {
          "id": 2,
          "text": "Bernard-Soulier syndrome"
        },
        {
          "id": 3,
          "text": "Disseminated intravascular coagulation"
        },
        {
          "id": 4,
          "text": "Wiskott-Aldrich syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>Wiskott&ndash;Aldrich syndrome </strong>(WAS). The given image shows (A) multiple petechiae over face and hematoma under the right eye and (B) eczema of the foot.&nbsp;</p>\n<p>This syndrome is an <strong>X-linked recessive,</strong>&nbsp;primary <strong>immunodeficiency</strong> disorder involving the WAS gene. It is characterised by the <strong>triad </strong>of:</p>\n<ul>\n<li>Severe eczema</li>\n<li>Thrombocytopenia</li>\n<li>Recurrent infections</li>\n</ul>\n<p><strong>Small platelets</strong> are seen in:</p>\n<ul>\n<li>Wiskott&ndash;Aldrich syndrome</li>\n<li>X-linked thrombocytopenia</li>\n</ul>\n<p><strong>Large platelets </strong>are seen in:</p>\n<ul>\n<li>Bernard-Soulier syndrome</li>\n<li>Myeloproliferative syndrome</li>\n<li>Myelodysplastic syndrome</li>\n<li>May&ndash;Hegglin anomaly</li>\n<li>Gray platelet syndrome</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9ac63126e8a842d9a7192bf63b487307.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5840",
      "difficulty": "medium"
    },
    {
      "text": "A 28-year-old woman presents with epistaxis, easy bruising and menorrhagia. There is no history of drug intake. Physical examination shows scattered petechiae and a normal-sized spleen. Her lab investigations are given below. Antibodies against which of the following can lead to this condition?<div class='question-desc-html'><p>Platelet count - 37,000/&mu;L</p>\n<p>Bleeding time - 16 minutes</p>\n<p>PT - 13 seconds</p>\n<p>aPTT - 30 seconds</p>\n<p>Peripheral blood smear - megathrombocytes</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "vWF"
        },
        {
          "id": 2,
          "text": "Glycoprotein IIb/IIIa"
        },
        {
          "id": 3,
          "text": "ADAMTS13"
        },
        {
          "id": 4,
          "text": "Thromboxane A2"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of<strong>&nbsp;chronic immune thrombocytopenic purpura</strong> (ITP). <strong>Autoantibodies</strong> seen in ITP are most often directed against platelet membrane <strong>glycoproteins</strong> <strong>IIb-IIIa</strong> or Ib-IX. It is<strong>&nbsp;</strong>a diagnosis of exclusion<strong>&nbsp;</strong>due to the&nbsp;following findings:</p>\n<ul>\n<li>Bleeding tendency - petechiae</li>\n<li>Low platelet count, elevated bleeding time</li>\n<li>Presence of megathrombocytes in the peripheral smear - a sign of accelerated thrombopoiesis</li>\n<li>Female preponderance</li>\n<li>Absence of splenomegaly</li>\n</ul>\n<p>&nbsp;Note: Prothrombin time (PT) is normal in ITP.</p><hr><h3>Related Pearl: Differences between Bleeding Disorders and Coagulation disorders</h3><table>\n<tbody>\n<tr>\n<td><strong>Finding</strong></td>\n<td><strong>Bleeding disorders</strong></td>\n<td><strong>Coagulation disorders</strong></td>\n</tr>\n<tr>\n<td>Cause</td>\n<td>\n<p>Quantitative/ Qualitative platelet abnormality</p>\n</td>\n<td>Deficiency of clotting factors</td>\n</tr>\n<tr>\n<td>Sex</td>\n<td>More common in females (commonly autoimmune)</td>\n<td>More common in males (commonly X-linked)</td>\n</tr>\n<tr>\n<td>Family history</td>\n<td>Rare (except in VWD)</td>\n<td>Common</td>\n</tr>\n<tr>\n<td>Petechiae</td>\n<td>Characteristic</td>\n<td>&nbsp;Rare</td>\n</tr>\n<tr>\n<td>Superficial ecchymosis</td>\n<td>Small and Multiple</td>\n<td>Large and Solitary</td>\n</tr>\n<tr>\n<td>Bleeding from superficial cuts&nbsp;</td>\n<td>Profuse</td>\n<td>Minimal persistent</td>\n</tr>\n<tr>\n<td>Hemarthrosis</td>\n<td>Rare</td>\n<td>Characteristic (most common-knee)</td>\n</tr>\n<tr>\n<td>Deep dissecting hematomas</td>\n<td>Rare</td>\n<td>Characteristic (most common-iliopsoas)</td>\n</tr>\n<tr>\n<td>Laboratory tests</td>\n<td>Bleeding time is prolonged</td>\n<td>PT and/or PTT are prolonged</td>\n</tr>\n<tr>\n<td>Most common</td>\n<td>Inherited: VWD</td>\n<td>\n<p>Inherited: Hemophilia A</p>\n<p>Acquired: Hemorrhagic diathesis of liver disease</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>VWD:&nbsp;von Willebrand disease</p>\n<p>PT: Prothrombin time</p>\n<p>PTT: Partial thromboplastin time</p><hr><h3>Related Pearl: Summary of Laboratory findings in Hemostatic Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Platelet count</strong></p>\n</td>\n<td>\n<p><strong>Bleeding time</strong></p>\n</td>\n<td>\n<p><strong>PT</strong></p>\n</td>\n<td>\n<p><strong>APTT</strong></p>\n</td>\n<td>\n<p><strong>Comments</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ITP</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Nomal</p>\n</td>\n<td>\n<p>Auto-Antibodies against IIb-IIIa or Ib-IX</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glanzmann thrombasthenia</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Defect in IIb/IIIa</p>\n<p>Autosomal recessive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bernard&ndash; Soulier syndrome</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Defect in Ib/IX</p>\n<p>Autosomal recessive</p>\n<p>Large platelets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>von Willebrand disease</p>\n</td>\n<td>\n<p>Low or normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>3 subtypes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemophilia A and B</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>X-linked inheritance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver disease</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin K deficiency</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>DIC</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increase in fibrin degradation products</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aspirin</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Warfarin</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>&uarr; (Even in</p>\n<p>low dose)</p>\n</td>\n<td>\n<p>&uarr; (Even in</p>\n<p>low dose)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ITP:&nbsp;Immune thrombocytopenic purpura</p>\n<p>DIC: Disseminated intravasculation coagulation</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5829",
      "difficulty": "medium"
    },
    {
      "text": "Which class of antiplatelet antibodies are seen in patients with chronic immune thrombocytopenic purpura?",
      "choices": [
        {
          "id": 1,
          "text": "Ig G"
        },
        {
          "id": 2,
          "text": "Ig A"
        },
        {
          "id": 3,
          "text": "Ig M"
        },
        {
          "id": 4,
          "text": "Ig E"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Antiplatelet antibodies</strong> in <strong>chronic</strong> immune thrombocytopenic purpura (<strong>ITP</strong>) are mainly <strong>IgG</strong> class.</p>\n<p>Autoantibodies most often directed against platelet membrane glycoproteins are IIb-IIIa or Ib-IX. It can be demonstrated in the plasma and bound to the platelet surface in about 80% of patients.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5831",
      "difficulty": "easy"
    },
    {
      "text": "A 27-year-old woman is diagnosed to have idiopathic ITP. Which of the following features is least likely to be seen in her?",
      "choices": [
        {
          "id": 1,
          "text": "Megathrombocytes"
        },
        {
          "id": 2,
          "text": "Petechiae and ecchymosis"
        },
        {
          "id": 3,
          "text": "Lymphadenopathy"
        },
        {
          "id": 4,
          "text": "Normal PT and PTT"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Lymphadenopathy</strong>&nbsp;and splenomegaly are uncommon in idiopathic (primary) ITP. They are seen in <strong>secondary</strong> <strong>ITP</strong>.</p>\n<p><strong>Chronic ITP</strong> occurs most commonly in adult women younger than 40 years of age.&nbsp;The female-to-male ratio is 3: 1.&nbsp;It<strong>&nbsp;</strong>is a <strong>type II hypersensitivity</strong> reaction. It is of 2 types:</p>\n<ul>\n<li>Primary or idiopathic - without any risk factors</li>\n<li>Secondary - presence of predisposing conditions like SLE, HIV, CLL</li>\n</ul>\n<p>Signs of accelerated thrombopoiesis that are seen in this condition are:</p>\n<ul>\n<li>Megakaryocytes in bone marrow</li>\n<li>Megathrombocytes (abnormally large platelets) in peripheral blood</li>\n</ul>\n<p>The image given below shows 2 megakaryocytes seen in bone marrow aspirate (Wrights stain).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/23c3c4d917114552a31d6213d52fa422x800x559.JPEG\" alt=\"Explanation Image\"><p><strong>Acute ITP</strong>&nbsp;is mainly a disease of childhood.&nbsp;It occurs with equal frequency in both sexes, mostly after a <strong>viral illness.</strong>&nbsp;It is self-limited condition, resolves within 6 months.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5832",
      "difficulty": "medium"
    },
    {
      "text": "Patients with which of the following predisposing conditions are likely to develop chronic immune thrombocytopenic purpura?<div class='question-desc-html'><ol>\n<li>Systemic lupus erythematosus</li>\n<li>HIV infection</li>\n<li>Chronic&nbsp;lymphocytic leukemia&nbsp;</li>\n<li>Rheumatoid arthritis</li>\n<li>Antiphospholipid antibody syndrome</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3"
        },
        {
          "id": 2,
          "text": "2, 3, 4, 5"
        },
        {
          "id": 3,
          "text": "1, 4, 5"
        },
        {
          "id": 4,
          "text": "1, 2, 3, 5"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Systemic lupus erythematosus, HIV infection, chronic&nbsp;lymphocytic leukemia, antiphospholipid antibody syndrome&nbsp;can predispose to the development of secondary immune thrombocytopenic purpura (ITP).</p>\n<p>The <strong>predisposing conditions</strong> of <strong>secondary</strong> chronic <strong>ITP</strong> include:</p>\n<ul>\n<li>Autoimmune conditions\n<ul>\n<li>Systemic lupus erythematosus (SLE)</li>\n<li>Antiphospholipid antibody syndrome (APS)</li>\n<li>Immune thyroid disease</li>\n<li>Evans syndrome</li>\n</ul>\n</li>\n<li>Lymphoproliferative diseases\n<ul>\n<li>Chronic lymphocytic leukemia</li>\n<li>Large granular T-lymphocyte lymphocytic leukemia</li>\n</ul>\n</li>\n<li>Chronic infection\n<ul>\n<li>Helicobacter pylori</li>\n<li>Human immunodeficiency virus (HIV)</li>\n<li>Hepatitis C virus (HCV)</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0496",
      "difficulty": "easy"
    },
    {
      "text": "A 63-year-old man with moderate COVID pneumonia developed DVT. Therapeutic anticoagulation with heparin was started. His lab investigations are given below. Which of the following is false about this condition?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Timing</strong></td>\n<td><strong>Platelet count</strong></td>\n</tr>\n<tr>\n<td>Before heparin therapy</td>\n<td>3,50,000 /&mu;L</td>\n</tr>\n<tr>\n<td>Day 3 of therapy</td>\n<td>3,20,000&nbsp;/&mu;L</td>\n</tr>\n<tr>\n<td>Day 7 of therapy</td>\n<td>53,000 /&mu;L&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Antibodies recognise heparin-platelet factor 4 complex"
        },
        {
          "id": 2,
          "text": "Lesser incidence with use of LMWH"
        },
        {
          "id": 3,
          "text": "Pulmonary thromboembolism is a complication"
        },
        {
          "id": 4,
          "text": "It is a self-resolving condition"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of <strong>type II</strong>&nbsp;heparin-induced thrombocytopenia (<strong>HIT</strong>). It is <strong>not self-resolving.</strong></p>\n<p>Thrombocytopenia occurs in about 5% of persons receiving heparin and is of two types:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>Type I</strong></td>\n<td><strong>Type II</strong></td>\n</tr>\n<tr>\n<td>Incidence</td>\n<td>More common</td>\n<td>Less common</td>\n</tr>\n<tr>\n<td>Occurrence&nbsp;</td>\n<td>Rapidly after onset of therapy</td>\n<td>5 to 14 days after therapy</td>\n</tr>\n<tr>\n<td>Pathogenesis</td>\n<td>Direct&nbsp;platelet-aggregating effect of heparin</td>\n<td>Antibodies against heparin-platelet factor 4 complexes</td>\n</tr>\n<tr>\n<td>Severity</td>\n<td>Less severe</td>\n<td>Often leads to life-threatening venous and arterial thrombosis</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>Self-resolving</td>\n<td>\n<p>Immediate discontinuation of heparin</p>\n<p>Alternate non-heparin anticoagulant to be used</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5834",
      "difficulty": "medium"
    },
    {
      "text": "All of the following commonly cause drug-induced thrombocytopenia except _____",
      "choices": [
        {
          "id": 1,
          "text": "Vancomycin"
        },
        {
          "id": 2,
          "text": "Quinine"
        },
        {
          "id": 3,
          "text": "Rifampin"
        },
        {
          "id": 4,
          "text": "Terlipressin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Terlipressin does not cause drug-induced thrombocytopenia.</p>\n<p>Drug-induced thrombocytopenia can be caused by:</p>\n<ul>\n<li>Vancomycin</li>\n<li>Quinine&nbsp;</li>\n<li>Rifampin</li>\n</ul>\n<p>They cause thrombocytopenia through <strong>direct effects</strong>&nbsp;on platelets or secondary&nbsp;to <strong>immunologically</strong> <strong>mediated</strong>&nbsp;platelet destructions.&nbsp;Quinine, quinidine, and&nbsp;vancomycin bind to platelet glycoprotein and&nbsp;create antigenic determinants&nbsp;that are recognized by antibodies.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0498",
      "difficulty": "medium"
    },
    {
      "text": "A post-operative patient was started on prophylactic unfractionated heparin for DVT. Which of the following is false regarding this drug?",
      "choices": [
        {
          "id": 1,
          "text": "It is an indirect thrombin-factor Xa inhibitor"
        },
        {
          "id": 2,
          "text": "It is safe in patients with renal impairment"
        },
        {
          "id": 3,
          "text": "It requires monitoring with aPTT"
        },
        {
          "id": 4,
          "text": "On development of HIT, LMWH can be started alternately"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The risk of severe heparin-induced thrombocytopenia is&nbsp;lowered with LMWH but not eliminated. Hence, once severe <strong>HIT</strong> <strong>develops</strong>&nbsp;even <strong>LMWH</strong> exacerbates the thrombotic tendency&nbsp;and&nbsp;must be <strong>avoided</strong>.</p>\n<p>Management of HIT includes the immediate withdrawal of heparin therapy and instituting an alternative non-heparin anticoagulant.</p><hr><h3>Related Pearl: Heparin vs. LMWH vs. Fondaparinux</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Features</strong></span></td>\n<td><span><strong>Unfractionated heparin</strong></span></td>\n<td><span><strong>LMWH</strong></span></td>\n<td><span><strong>Fondaparinux</strong></span></td>\n</tr>\n<tr>\n<td><strong><span>Structure</span></strong></td>\n<td>\n<p class=\"p1\"><span>A glycosaminoglycan consisting of long saccharide chains</span></p>\n</td>\n<td><span>A glycosaminoglycan consisting of short saccharide chains</span></td>\n<td><span>A synthetic pentasaccharide</span></td>\n</tr>\n<tr>\n<td><strong><span>Factor Xa inhibition&nbsp;</span></strong></td>\n<td><span>Yes</span></td>\n<td><span>Yes</span></td>\n<td><span>Yes</span></td>\n</tr>\n<tr>\n<td><strong><span>Factor IIa inhibition</span></strong></td>\n<td>\n<p><span>Yes (Xa = IIa)</span></p>\n<p><span>The long chains act Xa and IIa equally.</span></p>\n</td>\n<td>\n<p><span>Yes (Xa &gt; IIa)</span></p>\n<p><span>LMWH contains a mixture of long and short chains.</span></p>\n</td>\n<td>\n<p><span>No</span></p>\n<p><span>The pentasaccharide has no action on factor IIa</span></p>\n</td>\n</tr>\n<tr>\n<td><strong><span>Bioavailability</span></strong></td>\n<td>\n<p><span>Oral: Not absorbed</span></p>\n<p><span>S.C.: Not good&nbsp;<span>(longer chains are not absorbed well)&nbsp;</span></span></p>\n<p><span>I.V.: Good</span></p>\n</td>\n<td>\n<p><span>Oral: Not absorbed</span></p>\n<p><span>S.C.: Good&nbsp;</span></p>\n</td>\n<td>\n<p><span>Oral: Not absorbed</span></p>\n<p><span>S.C.: Very good</span></p>\n</td>\n</tr>\n<tr>\n<td><strong><span>Variable response</span></strong></td>\n<td><span>Yes&nbsp;</span></td>\n<td><span>No</span></td>\n<td><span>No</span></td>\n</tr>\n<tr>\n<td><strong><span>Metabolism</span></strong></td>\n<td><span>Cleared by the reticuloendothelial system</span>&nbsp;</td>\n<td><span>Cleared by the kidneys</span></td>\n<td><span>Cleared by the kidneys</span></td>\n</tr>\n<tr>\n<td><strong><span>Safety in renal disease</span></strong></td>\n<td><span>Safe in renal impairment</span></td>\n<td><span>Used with close monitoring</span></td>\n<td><span>Contraindicated in renal failure</span></td>\n</tr>\n<tr>\n<td><strong><span>Monitoring&nbsp;</span></strong></td>\n<td><span>Required, with <strong>aPTT</strong></span></td>\n<td><span>Required only in <strong>renal impairment</strong>,<strong>&nbsp;</strong>with <strong>anti-factor Xa assay</strong></span></td>\n<td><span>Not required</span></td>\n</tr>\n<tr>\n<td><strong><span>Protamine sulfate as antidote</span></strong></td>\n<td><span>Full reversal</span></td>\n<td><span>Partial reversal</span> <span>(acts only on the longer chains)</span></td>\n<td><span>No&nbsp;reversal</span></td>\n</tr>\n<tr>\n<td><strong><span>Risk of Heparin-induced thrombocytopenia</span></strong></td>\n<td><span>High&nbsp;</span></td>\n<td><span>Lower</span></td>\n<td><span>Least</span></td>\n</tr>\n<tr>\n<td><strong><span>Risk of osteoporosis</span></strong></td>\n<td><span>Occasionally</span></td>\n<td><span>Lower</span></td>\n<td><span>Lower</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/804286e8b58a478caeb89f36ccb6b8fbx1280x2261.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0497",
      "difficulty": "medium"
    },
    {
      "text": "Patients with which of the following conditions is associated with ADAMTS13 deficiency?",
      "choices": [
        {
          "id": 1,
          "text": "Immune thrombocytopenic purpura"
        },
        {
          "id": 2,
          "text": "Hemolytic uremic syndrome"
        },
        {
          "id": 3,
          "text": "Thrombotic thrombocytopenic purpura"
        },
        {
          "id": 4,
          "text": "Von Willebrand disease"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>ADAMTS13 deficiency</strong> is associated with thrombotic thrombocytopenic purpura (<strong>TTP</strong>).</p>\n<p>ADAMTS13 is also called <strong>vWF metalloprotease</strong> which <strong>degrades</strong> very high-molecular-weight <strong>multimers</strong> of von Willebrand factor (<strong>vWF</strong>). Its deficiency causes accumulation of these multimers in the plasma and promotes platelet activation and aggregation.</p>\n<p>TTP is a part of a spectrum of clinical syndromes called <strong>thrombotic microangiopathy.</strong>&nbsp;They are caused by insults that lead to excessive activation of platelets, which deposit as thrombi in small blood vessels.</p>\n<p><strong>Features</strong> of TTP include:</p>\n<ul>\n<li>Fever</li>\n<li>Thrombocytopenia</li>\n<li>Microangiopathic hemolytic anaemia</li>\n<li>Transient neurologic deficits</li>\n<li>Renal failure</li>\n</ul><hr><h3>Related Pearl: Differences between TTP and HUS</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><strong>TTP</strong></p>\n</td>\n<td>\n<p><strong>HUS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Causative agent</p>\n</td>\n<td>\n<p>A deficiency of, or antibodies to the metalloprotease ADAMTS13</p>\n</td>\n<td>\n<p>E. coli (O157: H7)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GI prodrome</p>\n</td>\n<td>\n<p>Uncommon</p>\n</td>\n<td>\n<p>Often</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Age group affected</p>\n</td>\n<td>\n<p>Adults</p>\n</td>\n<td>\n<p>Children</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sex affected</p>\n</td>\n<td>\n<p>Females</p>\n</td>\n<td>\n<p>No sex predilection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Relapses</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Renal impairment</p>\n</td>\n<td>\n<p>Usually mild</p>\n</td>\n<td>\n<p>Often severe</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Severe thrombocytopenia</p>\n</td>\n<td>\n<p>Often</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Pentad of TTP and triad of HUS</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f1004c9ccec548288509c1eaed783d3fx1280x1840.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5835",
      "difficulty": "easy"
    },
    {
      "text": "A 7-year-old girl is brought with complaints of hematuria and melena for 10 days. Laboratory investigations reveal mild thrombocytopenia and normal coagulation tests. Peripheral smear is given below. Which organism is most frequently involved in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "E.coli O157:H7"
        },
        {
          "id": 2,
          "text": "Shigella"
        },
        {
          "id": 3,
          "text": "Enteroinvasive E.coli"
        },
        {
          "id": 4,
          "text": "Salmonella"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario and peripheral smear showing <strong>helmet cells</strong> or <strong>schistocytes</strong> are suggestive of <strong>h</strong><strong>emolytic uremic syndrome </strong>(HUS)<strong>.&nbsp;</strong>This condition&nbsp;is most commonly associated with enterohemorrhagic&nbsp;<strong>Escherichia coli</strong> strain&nbsp;<strong>O157: H7&nbsp;</strong>worldwide.</p>\n<p>This strain releases<strong>&nbsp;Shiga-like toxin</strong>.&nbsp;This toxin is absorbed from the inflamed gastrointestinal mucosa into the circulation and causes <strong>endothelial</strong> <strong>dysfunction</strong>. It leads to <strong>platelet </strong>activation and <strong>aggregation</strong>. Children and older adults are at the highest risk.</p>\n<p>The image given below shows schistocytes or helmet cells seen in HUS.&nbsp;&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ed110bae6299454e81bda8f6e444230fx799x600.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Differences between TTP and HUS</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><strong>TTP</strong></p>\n</td>\n<td>\n<p><strong>HUS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Causative agent</p>\n</td>\n<td>\n<p>A deficiency of, or antibodies to the metalloprotease ADAMTS13</p>\n</td>\n<td>\n<p>E. coli (O157: H7)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GI prodrome</p>\n</td>\n<td>\n<p>Uncommon</p>\n</td>\n<td>\n<p>Often</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Age group affected</p>\n</td>\n<td>\n<p>Adults</p>\n</td>\n<td>\n<p>Children</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sex affected</p>\n</td>\n<td>\n<p>Females</p>\n</td>\n<td>\n<p>No sex predilection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Relapses</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Renal impairment</p>\n</td>\n<td>\n<p>Usually mild</p>\n</td>\n<td>\n<p>Often severe</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Severe thrombocytopenia</p>\n</td>\n<td>\n<p>Often</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Pentad of TTP and triad of HUS</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f1004c9ccec548288509c1eaed783d3fx1280x1840.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9d74b8d51ae54c0b8d11fd94e1a8222d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5837",
      "difficulty": "easy"
    },
    {
      "text": "Deficiency of which of the following complement components is not associated with atypical hemolytic uremic syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Factor H"
        },
        {
          "id": 2,
          "text": "CD46"
        },
        {
          "id": 3,
          "text": "Factor I"
        },
        {
          "id": 4,
          "text": "CD59"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Atypical hemolytic uremic syndrome</strong> is not associated with deficiency of CD59.</p>\n<p>It<strong>&nbsp;</strong>is&nbsp;<strong>associated</strong> with <strong>deficiency</strong>&nbsp;of the following components:</p>\n<ul>\n<li>Complement factor H</li>\n<li>Membrane cofactor protein (CD46)</li>\n<li>Complement factor I</li>\n</ul>\n<p>These&nbsp;three proteins <strong>prevent</strong> <strong>excessive</strong> <strong>activation</strong> of the <strong>alternative</strong> <strong>complement</strong> pathway.</p>\n<p>Deficiencies of these proteins can be caused by inherited defects or acquired inhibitory autoantibodies. The disease may be associated with a remitting, relapsing course.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5838",
      "difficulty": "easy"
    },
    {
      "text": "Coombs test is found to be positive in a patient with thrombocytopenia. Which of the following conditions could be a likely cause?",
      "choices": [
        {
          "id": 1,
          "text": "Thrombotic thrombocytopenic purpura"
        },
        {
          "id": 2,
          "text": "Hemolytic uremic syndrome"
        },
        {
          "id": 3,
          "text": "Immune thrombocytopenic purpura"
        },
        {
          "id": 4,
          "text": "Disseminated intravascular coagulation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><span class=\"TextRun SCXW155232901\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW155232901\"><strong>Coombs test</strong> is <strong>positive</strong> in immune thrombocytopenic purpura (<strong>ITP</strong>) as it is an <strong>immunogenic</strong> cause of thrombocytopenia. </span></span></p>\n<p><span class=\"TextRun SCXW155232901\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW155232901\">Thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS) and disseminated intravascular coagulation (DIC) are&nbsp;</span></span><span class=\"TextRun SCXW155232901\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW155232901\">nonimmunogenic</span></span><span class=\"TextRun SCXW155232901\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW155232901\">&nbsp;causes. Hence, Coombs test is negative in these conditions.</span></span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fed5d26856c9438791b8f719e7cd9b1dx1280x1927.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0510",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is affected in patients with Weber-Osler-Rendu syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Collagen"
        },
        {
          "id": 2,
          "text": "Platelets"
        },
        {
          "id": 3,
          "text": "Clotting factors"
        },
        {
          "id": 4,
          "text": "Blood vessels"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Weber&ndash;Osler&ndash;Rendu syndrome</strong> is a disorder of the <strong>blood vessels</strong>.</p>\n<p>It is an <strong>autosomal-dominant</strong> disorder caused by mutations that modulate TGF-&beta; signalling. It is also known as <strong>hereditary hemorrhagic telangiectasia</strong>.&nbsp;</p>\n<p>This condition is characterized by dilated, <strong>tortuous blood vessels</strong> with thin walls that <strong>bleed</strong> readily.&nbsp;Bleeding is most common in the mucous membranes of the nose (epistaxis), tongue, mouth, and eyes, and throughout the gastrointestinal tract.</p>\n<p>Platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT) are normal.</p>\n<p>Clinical conditions in which <strong>abnormalities</strong> of <strong>vessel wall</strong> cause <strong>bleeding </strong>include<strong>:</strong></p>\n<ul>\n<li>Infections - meningococcemia, infective endocarditis, rickettsioses</li>\n<li>Collagen defects - Ehlers&ndash;Danlos syndrome, scurvy, and Cushing's syndrome</li>\n<li>Perivascular amyloidosis - most common with amyloid light-chain (AL) amyloidosis</li>\n<li>Henoch&ndash;Sch&ouml;nlein purpura</li>\n<li>Drug reactions</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5825",
      "difficulty": "hard"
    }
  ]
}